Biostax Corp. booked $113.5k in FY2018 revenue, growing 3178% year over year — faster than 98% of Healthcare companies we track, at a -1454.2% net margin.
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.